Torigen Pharmaceuticals
Chemicals & Related Products · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Farmington Ave R1855 CB129, Farmingt...Website
www.torigen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Torigen Pharmaceuticals
Torigen Pharmaceuticals Inc. is focused on delivering affordable companion animal immuno-oncology products. Its initial patented product line utilizes a portion of the pet-patient's tumor to create a personalized cancer vaccine. With over ten years of supporting pre-clinical publications, the Torigen team is focused on developing innovative veterinary cancer biologics that allow for the body to recognize foreign tumor-associated antigens and facilitate the reversal of immune senescence.Explore more
Torigen Pharmaceuticals Org Chart
NP
Manager, Production Assurance
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Torigen Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Torigen Pharmaceuticals recently announced quarterly report
Check out if Torigen Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Torigen Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Torigen Pharmaceuticals launches new products
Check if Torigen Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Torigen Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Torigen Pharmaceuticals
Funding: Get notified immidiatlly once Torigen Pharmaceuticals has new funding data
Recommended Actions
Reach out to Masked Content who joined Torigen Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Torigen Pharmaceuticals
Compare insights from companies similar to Torigen Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Torigen Pharmaceuticals
<$5M
11-50
Private
$16.1M
2013
AS
Amanda SosikManager, Internal Veterinary Client Services
Company Profile Activity
Activity Insights
Torigen Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Torigen Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Torigen Pharmaceuticals.
Torigen Pharmaceuticals financials insights
Gather financial insights about Torigen Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$3.1M
2022
Series A
$13M
Torigen Pharmaceuticals Tech Stack
A closer look at the technologies used by Torigen Pharmaceuticals
Most Recent Scoops
New Hire
Executive Move
Torigen Pharmaceuticals has announced that Arthur Polk has joined the organization as Chief Operating Officer.
Promotion
Executive Move
Promotion
Executive Move
Facilities Relocation / Expansion
Facilities Relocation/Expansion
Funding
Torigen Pharmaceuticals News & Media
Torigen Launches Specialty Pathology Service To Deliver Expert Cancer Diagnoses For Pets
Torigen's New Specialty Pathology Service Deliver Answers from Experts in Treating Pets with Cancer FARMINGTON, Conn., Dec. 10, 2024 /PRNewswire-PRWeb/ -- Torigen Pharmaceuticals, recognized for pioneering cancer immunotherapy in veterinary medicine with its personalized cancer vaccine,...Torigen Pharmaceuticals Opens New Headquarters and Promotes Two to...
Connecticut-based animal biologics company builds momentum in Q2 2023 with state-of-the-art production facility and team expansion (PRWeb April 25, 2023) Read the full story at https://www.prweb.com/releases/torigen_pharmaceuticals_opens_new_headquarters_and_promotes_two_to_executive_leadership/prweb19299394.htmTorigen Pharmaceuticals and Veterinary Management Groups Enter into Preferred Partner Agreement
Agreement provides member clinics and their patients with access to innovative companion animal cancer therapy (PRWeb April 13, 2023) Read the full story at https://www.prweb.com/releases/torigen_pharmaceuticals_and_veterinary_management_groups_enter_into_preferred_partner_agreement/prweb19279742.htmTorigen Pharmaceuticals and VerticalVet Enter into Preferred Partnership
Agreement provides access to innovative companion animal cancer therapy to GPO members and their clients (PRWeb December 08, 2022) Read the full story at https://www.prweb.com/releases/torigen_pharmaceuticals_and_verticalvet_enter_into_preferred_partnership/prweb19064474.htm
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Torigen Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Torigen Pharmaceuticals Inc. is focused on delivering affordable companion animal immuno-oncology products. Its initial patented product line utilizes a portion of the pet-patient's tumor to create a personalized cancer vaccine. With over ten years of supporting pre-clinical publications, the Torigen team is focused on developing innovative veterin... Read More
